Financials

News Discussions Technicals Forecast Seasonals

Diluted shares outstanding of NeuroSense Therapeutics Ltd.

Annual data

2020

2021

2022

2023

TTM

‪0.00‬

‪‪4.00 M‬‬

‪‪8.00 M‬‬

‪‪12.00 M‬‬

‪‪16.00 M‬‬

Period

Value

Change

Change %

TTM

—

—

—

2023

‪‪13.64 M‬‬

+‪‪2.14 M‬‬

+‪18.56‬%

2022

‪‪11.50 M‬‬

+‪‪9.56 M‬‬

+‪492.72‬%

2021

‪‪1.94 M‬‬

‪0.00‬

‪0.00‬%

2020

‪‪1.94 M‬‬

‪0.00‬

‪0.00‬%

Quarterly data

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

‪‪5.00 M‬‬

‪‪10.00 M‬‬

‪‪15.00 M‬‬

‪‪20.00 M‬‬

Period

Value

Change

Change %

Q3 '24

‪‪19.81 M‬‬

+‪‪1.75 M‬‬

+‪9.71‬%

Q2 '24

‪‪18.06 M‬‬

+‪‪2.65 M‬‬

+‪17.20‬%

Q1 '24

‪‪15.41 M‬‬

+‪‪26.21 K‬‬

+‪0.17‬%

Q4 '23

‪‪15.38 M‬‬

+‪‪1.76 M‬‬

+‪12.89‬%

Q3 '23

‪‪13.62 M‬‬

‪−2.00‬

‪0.00‬%

Q2 '23

‪‪13.62 M‬‬

+‪‪1.84 M‬‬

+‪15.60‬%

Q1 '23

‪‪11.78 M‬‬

+‪‪2.89 K‬‬

+‪0.02‬%

Q4 '22

‪‪11.78 M‬‬

+‪‪107.98 K‬‬

+‪0.92‬%

Q3 '22

Q2 '22